selegiline has been researched along with ditiocarb in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dansette, PM; Fontana, E; Poli, SM | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Bizière, K; Guillaumin, JM; Kan, JP; Renoux, G; Renoux, M; Steinberg, R | 1 |
| Boor, PJ; Hysmith, RM | 1 |
| Corsini, GU; Fascetti, F; Fornai, F; Maggio, R; Vaglini, F | 1 |
| Cavalletti, M; Corsini, GU; Fascetti, F; Fornai, F; Tedeschi, D; Vaglini, F | 1 |
| Clow, A; Gallagher, IM; Glover, V | 1 |
| Iida, Y; Ogawa, M; Saji, H; Shimazu, S; Takahata, K; Yoneda, F | 1 |
| Iida, Y; Saji, H; Shimazu, S; Takahata, K; Tamashiro, A; Yoneda, F | 1 |
1 review(s) available for selegiline and ditiocarb
| Article | Year |
|---|---|
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
8 other study(ies) available for selegiline and ditiocarb
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Sodium diethyldithiocarbamate protects against the MPTP-induced inhibition of immune responses in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; B-Lymphocytes; Corpus Striatum; Designer Drugs; Ditiocarb; Dopamine; Homovanillic Acid; Immune System; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Male; Metallothionein 3; Mice; Mitogens; Pyridines; Selegiline; T-Lymphocytes | 1989 |
Purification of benzylamine oxidase from cultured porcine aortic smooth muscle cells.
Topics: 4-Chloromercuribenzenesulfonate; Animals; Aorta; Benzylamine Oxidase; Cells, Cultured; Cholic Acids; Chromatography, High Pressure Liquid; Cuprizone; Ditiocarb; Electrophoresis, Polyacrylamide Gel; Immunodiffusion; Molecular Weight; Monoamine Oxidase; Muscle, Smooth, Vascular; Selegiline; Semicarbazides; Swine | 1988 |
(+)MK-801 prevents the DDC-induced enhancement of MPTP toxicity in mice.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Ditiocarb; Dizocilpine Maleate; Dopamine; Drug Synergism; Haplorhini; Homovanillic Acid; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Piperazines; Selegiline; Substantia Nigra; Tyrosine 3-Monooxygenase | 1994 |
Striatal MPP+ levels do not necessarily correlate with striatal dopamine levels after MPTP treatment in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Acetaldehyde; Animals; Chromatography, High Pressure Liquid; Clonidine; Corpus Striatum; Ditiocarb; Dizocilpine Maleate; Dopamine; Dopamine Uptake Inhibitors; Kinetics; Male; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; MPTP Poisoning; Nicotine; Piperazines; Selegiline; Serotonin | 1996 |
Long-term administration of (-)-deprenyl increases mortality in male Wistar rats.
Topics: Animals; Antioxidants; Body Weight; Death; Ditiocarb; Dopamine Agonists; Feeding Behavior; Humans; Longevity; Male; Monoamine Oxidase Inhibitors; Pergolide; Rats; Rats, Wistar; Selegiline | 1998 |
Effects of monoamine oxidase inhibitors on the diethyldithiocarbamate-induced enhancement of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in C57BL/6 mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Body Weight; Cell Death; Clorgyline; Disease Models, Animal; Ditiocarb; Dopamine; Down-Regulation; Drug Synergism; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Neostriatum; Neuroprotective Agents; Parkinsonian Disorders; Presynaptic Terminals; Selegiline; Substantia Nigra | 2003 |
Recovery of motor function and dopaminergic parameters in a mouse model of Parkinson's disease induced by co-administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and diethyldithiocarbamate.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Ditiocarb; Dopamine; Drug Synergism; Homovanillic Acid; Levodopa; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Motor Activity; Parkinsonian Disorders; Reaction Time; Recovery of Function; Selegiline; Serotonin | 2003 |